Top compounds associated with response to TRABD2B


Feature Type Standardized
Nominal ANOVA
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.0096 0.8
mRNA DBeQ CTRPv2 pan-cancer AAC 0.011 0.8
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.8
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA BMS-345541 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.8
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.01 0.8
mRNA Docetaxel gCSI pan-cancer AAC -0.016 0.8
Download CSV